NCT01981005View on ClinicalTrials.gov

A Study of the Elimination, Pharmacokinetics, and Metabolism of RO5424802

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

RO5424802

Single oral doses followed by IV or oral administration of a 14C-labeled tracer

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01981005 - A Study of the Elimination, Pharmacokinetics, and Metabolism of RO5424802 | Biotech Hunter | Biotech Hunter